First Time Loading...

Sonendo Inc
NYSE:SONX

Watchlist Manager
Sonendo Inc Logo
Sonendo Inc
NYSE:SONX
Watchlist
Price: 0.1059 USD -0.09% Market Closed
Updated: Mar 29, 2024

Intrinsic Value

SONX's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Sonendo, Inc. is a medical technology company that has developed and is commercializing the GentleWave System to treat tooth decay. [ Read More ]

The intrinsic value of one SONX stock under the Base Case scenario is 1.6206 USD. Compared to the current market price of 0.1059 USD, Sonendo Inc is Undervalued by 93%.

Key Points:
SONX Intrinsic Value
Base Case
1.6206 USD
Undervaluation 93%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Fundamental Analysis

How can I assist you today?

Provide an overview
of Sonendo Inc's business.

What risks and challenges
does Sonendo Inc face in the near future?

Summarize the latest earnings report
of Sonendo Inc.

Provide P/E
for Sonendo Inc and its competitors.

Financials

Balance Sheet Decomposition
Sonendo Inc

Current Assets 75.5m
Cash & Short-Term Investments 55.9m
Receivables 5.6m
Other Current Assets 14m
Non-Current Assets 12.8m
PP&E 3.5m
Intangibles 9.2m
Other Non-Current Assets 100k
Current Liabilities 11.1m
Accounts Payable 1m
Accrued Liabilities 8.3m
Other Current Liabilities 1.8m
Non-Current Liabilities 39.4m
Long-Term Debt 37.2m
Other Non-Current Liabilities 2.2m
Efficiency

Earnings Waterfall
Sonendo Inc

Revenue
44.4m USD
Cost of Revenue
-32.8m USD
Gross Profit
11.6m USD
Operating Expenses
-70.8m USD
Operating Income
-59.2m USD
Other Expenses
-1.7m USD
Net Income
-60.9m USD

Free Cash Flow Analysis
Sonendo Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

SONX Profitability Score
Profitability Due Diligence

Sonendo Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Positive Gross Profit
Positive 1-Year Revenue Growth
Negative Operating Income
23/100
Profitability
Score

Sonendo Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

SONX Solvency Score
Solvency Due Diligence

Sonendo Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
Low D/E
39/100
Solvency
Score

Sonendo Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SONX Price Targets Summary
Sonendo Inc

Wall Street analysts forecast SONX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SONX is 0.25 USD .

Lowest
Price Target
Not Available
Average
Price Target
0.25 USD
136% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

SONX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

SONX Price
Sonendo Inc

1M 1M
-41%
6M 6M
-86%
1Y 1Y
-94%
3Y 3Y
-99%
5Y 5Y
-99%
10Y 10Y
-99%
Annual Price Range
0.1059
52w Low
0.0582
52w High
2.01
Price Metrics
Average Annual Return -56.36%
Standard Deviation of Annual Returns 6.52%
Max Drawdown -100%
Shares Statistics
Market Capitalization 6.7m USD
Shares Outstanding 63 547 467
Percentage of Shares Shorted 0.92%

SONX Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Sonendo Inc Logo
Sonendo Inc

Country

United States of America

Industry

Health Care

Market Cap

6.7m USD

Dividend Yield

0%

Description

Sonendo, Inc. is a medical technology company that has developed and is commercializing the GentleWave System to treat tooth decay. The company is headquartered in Laguna Hills, California and currently employs 219 full-time employees. The company went IPO on 2021-10-29. The firm has developed GentleWave System, a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company is focused on leveraging the GentleWave System, a root canal therapy for late-stage tooth decay that employs a sterilized, single-use procedure instrument. In addition to its GentleWave console and single-use procedure instruments, it also offers single-use products, such as SoundSeal and the Company's Sonendo-branded liquid solution of ethylenediaminetetraacetic acid (EDTA). SoundSeal is a material used during the GentleWave Procedure to build and create a sealing platform on the top of the crown. Its EDTA is a liquid used during the GentleWave Procedure to help debride and disinfect the root canal system. The company also offers TDO practice management software.

Contact

CALIFORNIA
Laguna Hills
26061 Merit Circle, Suite 101
+19497663636.0
http://sonendo.com/

IPO

2021-10-29

Employees

219

Officers

President, CEO & Director
Mr. Bjarne Bergheim
Executive Director
Mr. Olav B. Bergheim
CFO & Corporate Secretary
Mr. Michael P. Watts
Vice President of Operations
Mr. John P. McGaugh
Vice President of Marketing
Bob Guyatt
Chief Talent Officer
Mr. Roy T. Chen
Show More
VP of Finance & Controller
Mr. Chris Guo
Show Less

See Also

Discover More